Multiple myeloma combo trial halted after just 4 patients
NCT ID NCT06163898
First seen May 06, 2026 · Last updated May 23, 2026 · Updated 3 times
Summary
This early-stage study aimed to find the best dose and check the safety of combining alnuctamab and mezigdomide for people with multiple myeloma that had come back or stopped responding to treatment. Only 4 participants were enrolled before the study was stopped early. The main goals were to track side effects and see if the combination helped control the cancer.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTIPLE MYELOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Local Institution - 0018
New York, New York, 10065, United States
-
Local Institution - 0020
Jerusalem, 9112001, Israel
-
Local Institution - 0021
Petah Tikva, Central District, 4910021, Israel
-
Local Institution - 0030
Ramat Gan, Central District, 5262100, Israel
-
Local Institution - 0033
Birmingham, Alabama, 35294, United States
-
Local Institution - 0035
New Haven, Connecticut, 06511, United States
Conditions
Explore the condition pages connected to this study.